Table 4.
Study | OR | CI Lower Limit |
CI Upper Limit |
Weight |
---|---|---|---|---|
Santino et al., 2004 [45] | 6.50 | 2.26 | 18.73 | 13.92% |
Tomao et al., 2005 [46] | 0.67 | 0.22 | 2.04 | 13.43% |
Cisak et al., 2005 [47] | 8.93 | 3.00 | 26.60 | 13.62% |
Rojko et al., 2005 [48] | 2.91 | 1.30 | 6.53 | 16.90% |
Cisak et al., 2008 [49] | 7.71 | 2.20 | 27.03 | 11.98% |
Kaya et al., 2008 [50] | 0.78 | 0.03 | 17.93 | 3.41% |
Buczek et al., 2009 [51] | 2.09 | 1.45 | 3.02 | 22.93% |
Di Rienzi et al., 2010 [52] | 1.67 | 0.11 | 24.94 | 4.71% |
Until 2010 | 3.03 | 1.39 | 6.61 | 47.14% |
Cisak et al., 2012 [54] | 2.55 | 0.59 | 11.00 | 8.16% |
Tabibi et al., 2013 [56] | 0.59 | 0.15 | 2.42 | 8.56% |
Jovanovic, 2015 [57] | 1.00 | 0.10 | 10.31 | 3.93% |
Bucak, 2016 [60] | 0.54 | 0.19 | 1.53 | 14.26% |
De Keukeleire et al., 2016 [61] | 2.46 | 0.51 | 11.85 | 6.98% |
Cora et al., 2017 [65] | 0.89 | 0.56 | 1.41 | 41.29% |
De Keukeleire et al., 2017 [66] | 2.03 | 0.80 | 5.16 | 16.81% |
After 2011 | 1.08 | 0.63 | 1.85 | 52.86% |
Combined effect size | 1.76 | 0.58 | 5.29 |